Can SGLT-2 inhibitors resolve the heart failure burden of diabetes mellitus - Is it empaglifozin or the class?

被引：0
|
作者：
Tschoepe, Diethelm [1 ]
机构：
[1] Ruhr Univ Bochum, Heart & Diabet Ctr North Rhine Westphalia Bad Oey, Diabet Ctr, Bochum, Germany
来源：
JOURNAL OF DIABETES AND ITS COMPLICATIONS | 2017年 / 31卷 / 07期
关键词：
EMPAGLIFLOZIN; MORTALITY; OUTCOMES; TYPE-1;
D O I：
10.1016/j.jdiacomp.2017.04.020
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：1075 / 1076
页数：2
相关论文
共 50 条
  • [21] SGLT-2 Inhibitors in Heart Failure: Guide for Prescribing and Future Perspectives
    Garla, Vishnu Vardhan
    Butler, Javed
    Lien, Lillian F.
    CURRENT CARDIOLOGY REPORTS, 2021, 23 (06)
  • [22] SGLT-2 Inhibitors in Heart Failure: Guide for Prescribing and Future Perspectives
    Vishnu Vardhan Garla
    Javed Butler
    Lillian F. Lien
    Current Cardiology Reports, 2021, 23
  • [23] SGLT-2 Inhibitors in Type 1 Diabetes Mellitus: A Comprehensive Review of the Literature
    Patoulias, Dimitrios
    Imprialos, Konstantinos
    Stavropoulos, Konstantinos
    Athyros, Vasilios
    Doumas, Michael
    CURRENT CLINICAL PHARMACOLOGY, 2018, 13 (04): : 261 - 272
  • [24] SGLT-2 Inhibitors: The Next-generation Treatment for Type 2 Diabetes Mellitus
    Lukic, Nikola
    Macvanin, Mirjana T.
    Gluvic, Zoran
    Rizzo, Manfredi
    Radak, Djordje
    Suri, Jasjit S.
    Isenovic, Esma R.
    CURRENT MEDICINAL CHEMISTRY, 2024, 31 (30) : 4781 - 4806
  • [25] SGLT-2 inhibitors and their potential in the treatment of diabetes
    Rosenwasser, Rebecca F.
    Sultan, Senan
    Sutton, David
    Choksi, Rushab
    Epstein, Benjamin J.
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2013, 6 : 453 - 467
  • [26] SGLT-2 inhibitors in diabetes: a focus on renoprotection
    Gonzalez, Diego Ennes
    Foresto, Renato Demarchi
    Ribeiro, Artur Beltrame
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2020, 66 : S17 - S24
  • [27] SGLT-2 Inhibitors in Heart Failure and Type-2 Diabetes: Hitting Two Birds with One Stone?
    Santos-Ferreira, Diogo
    Goncalves-Teixeira, Pedro
    Fontes-Carvalho, Ricardo
    CARDIOLOGY, 2020, 145 (05) : 311 - 320
  • [28] Effect of the SGLT-1 and SGLT-2 Inhibitors Sotagliflozine on the Treatment of Type 1 Diabetes mellitus
    Pavlicek, Vojtech
    DIABETOLOGE, 2019, 15 (06): : 585 - 586
  • [29] SGLT-2 inhibitors in heart failure: real world experience in a chronic heart failure care unit
    Ines Barradas Da Silva, M. Maria
    Duarte, F.
    Castro, J.
    Oliveira, L.
    Serena, C.
    Fontes, A.
    Monteiro, A.
    Machado, C.
    Dourado, R.
    Santos, E.
    Pelicano, N.
    Pacheco, M.
    Tavares, A.
    Martins, D.
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 : 204 - 204
  • [30] Role of SGLT-2 inhibitors in patients with heart failure and preserved ejection fraction
    Schwinger, Robert H. G.
    Nitschmann, Sirka
    INNERE MEDIZIN, 2023, 64 (02): : 211 - 213
12345